To determine the effect of RAD21 on ovarian cancer cell proliferation when treated with PARP inhibitors, cells were transfected with siRNA or lentivirus and treated with the indicated concentration of PARP inhibitors for 4 days. Here, RAD21 is linked to ovarian cancer.